Biblio Discovery — Demo Discovery Service

5 hasil untuk "Matthias Pinter"

Menampilkan 1–5 · 0,25 detik · RSS

  1. Artikel Jurnal Teks lengkap

    The impact of thyroid hormones on patients with hepatocellular carcinoma

    Matthias Pinter; Lukas Haupt; Florian Hucke dkk.

    PLOS ONE, Vol. 12 No. 8 · 2017 · Inggris · PLOS Scopus

    Background & aims: Hypothyroidism has recently been proposed as predisposing factor for HCC development. However, the role of thyroid hormones (TH) in established HCC is largely unclear. We investigated the impact of TH on clinical characteristics and prognosis of HCC patients. Methods: Of 838…

  2. Artikel Jurnal Teks lengkap

    Early changes in immunoglobulin G levels during immune checkpoint inhibitor treatment are associated with survival in hepatocellular carcinoma patients

    Lorenz Balcar; David Bauer; Katharina Pomej dkk.

    PLOS ONE, Vol. 18 No. 4 · 2023 · Inggris · PLOS Scopus

    Background & aims: Immunotherapy represents the new standard of care in systemic first-line treatment of hepatocellular carcinoma (HCC). Biomarkers that predict treatment response and survival remain an unmet clinical need. Methods: Patients with HCC treated with immune-checkpoint inhibitors (ICI)…

  3. Artikel Jurnal Teks lengkap

    C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation

    Tobias Meischl; Susanne Rasoul-Rockenschaub; Georg Györi dkk.

    PLOS ONE, Vol. 14 No. 5 · 2019 · Inggris · PLOS Scopus

    Background: Serum C-reactive protein (CRP) is a prognostic factor for overall survival (OS) and recurrence of hepatocellular carcinoma (HCC) in patients treated with resection or non-surgical treatment. Here, we investigated the association of elevated CRP (≥1 vs.

  4. Artikel Jurnal Teks lengkap

    COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital

    Katharina Pomej; Bernhard Scheiner; Lukas Hartl dkk.

    PLOS ONE, Vol. 16 No. 8 · 2021 · Inggris · PLOS Scopus

    Background: Patients with hepatocellular carcinoma (HCC) represent a vulnerable population potentially negatively affected by COVID-19-associated reallocation of healthcare resources. Here, we report the impact of COVID-19 on the management of HCC patients in a large tertiary care hospital…

  5. Artikel Jurnal Teks lengkap

    Study protocol: Fecal Microbiota Transplant combined with Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma who failed to achieve or maintain objective response to Atezolizumab/Bevacizumab – the FAB-HCC pilot study

    Katharina Pomej; Adrian Frick; Bernhard Scheiner dkk.

    PLOS ONE, Vol. 20 No. 4 · 2025 · Inggris · PLOS Scopus

    Background: The gut microbiota is often altered in chronic liver diseases and hepatocellular carcinoma (HCC), and increasing evidence suggests that it may influence response to cancer immunotherapy. Strategies to modulate the gut microbiome (i.e., fecal microbiota transplant (FMT)) may help to…